Drug Shortage Report for RESONIUM CALCIUM

Last updated on 2019-10-15 History
Report ID 84937
Drug Identification Number 02017741
Brand name RESONIUM CALCIUM
Common or Proper name Resonium Calcium
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) CALCIUM POLYSTYRENE SULFONATE
Strength(s) 999MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration ORAL RECTAL
Packaging size 1
ATC code V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-06-07
Actual start date
Estimated end date 2019-09-30
Actual end date 2019-08-13
Shortage status Resolved
Updated date 2019-10-15
Company comments The anticipated availability dates represent estimated availabilities at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-10-15 French Compare
v6 2019-10-15 English Compare
v5 2019-06-08 English Compare
v4 2019-05-28 French Compare
v3 2019-05-28 English Compare
v2 2019-05-28 French Compare
v1 2019-05-28 English Compare